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Abstract
Objectives Diarrheal diseases (DD) are an important cause
of disease burden, especially in children in low-income
settings. DD can also impact children’s potential livelihood
through growth faltering, cognitive impairment, and other
sequelae.
Methods As part of the Global Burden of Disease study,
we estimated DD burden, and the burden attributable to
specific risk factors and etiologies, in the Eastern
Mediterranean Region (EMR) between 1990 and 2015. We
calculated disability-adjusted life-years (DALYs)—the
sum of years of life lost and years lived with disability—for
both sexes and all ages.
Results We estimate that over 103,692 diarrhea deaths
occurred in the EMR in 2015 (95% uncertainty interval:
87,018–124,692), and the mortality rate was 16.0 deaths
per 100,000 persons (95% UI: 13.4–19.2). The majority of
these deaths occurred in children under 5 (63.3%) (65,670
deaths, 95% UI: 53,640–79,486). DALYs per 100,000
ranged from 304 (95% UI 228–400) in Kuwait to 38,900
(95% UI 25,900–54,300) in Somalia.
Conclusions Our findings will guide evidence-based health
policy decisions for interventions to achieve the ultimate
goal of reducing the DD burden.
Keywords Eastern Mediterranean Region  Burden of
disease  Diarrheal diseases
Introduction
Rigorous public health efforts resulted in a significant
decline in mortality due to diarrheal diseases (DD) over the
past 20 years. However, these diseases continue to cause a
major global disease burden, especially in children under
5 years of age. In addition, the incidence of childhood
diarrhea in low-income countries has not declined as
rapidly as mortality (GBD 2015 Risk Factors Collaborators
2016). In the most recent Global Burden of Disease (GBD)
study, DD was the fourth-leading cause of death among
children under 5, responsible for 499,000 deaths (95% UI:
447,000–558,000), representing 8.6% of all deaths in this
age group (GBD 2015 Risk Factors Collaborators 2016).
For those who survive these illnesses and suffer from
repeated infections by enteric pathogens during the critical
early years of life; DD can lead to serious, lifelong health
consequences such as environmental enteric dysfunction
(EED), growth faltering, impaired cognitive development,
and reduced immune response to infection and vaccina-
tions (Guerrant et al. 2013).
DD pathogen etiologic contribution may vary depending
on the study’s geographic location, duration, or the popu-
lation sampled (Lindsay et al. 2015). These infections are
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believed to be different in the developing world compared
to the developed world with regard to a number of features,
including earlier age of onset, multiple repeated exposures,
greater diversity of pathogens, nutritional status of the host,
and a number of others, such as co-infection, diet, and
genetics (Heidt et al. 2014).
The Eastern Mediterranean Region (EMR) is home to
more than 500 million people, representing a diverse group
of 22 countries. EMR countries have diverse historical
backgrounds, political and social contexts, and fiscal and
cultural influences on their health care systems. The region
has wide variation in per capita gross national product
(GNP) (The World Bank 2016), which has a major influ-
ence on overall health spending and results in substantial
health inequities both within and across countries. During
recent years DD prevention efforts that focus on vaccines
in the short term and improvements in water, sanitation,
and hygiene in the long term have been impeded by war-
fare and political unrest in the region. These conflicts and
wars also resulted in a huge problem of internal displace-
ment and refugees (Mokdad et al. 2016).
Many countries in the EMR achieved important suc-
cesses in the fight against DD in the 1970s and 1980s with
the support of United Nations International Children’s
Emergency Fund (UNICEF) and the World Health Orga-
nization (WHO) through the National Control of Diarrheal
Diseases Project (NCDDP) (WHO 1992; Enzley et al.
1997). For example, Egypt’s program, which spanned from
1981 to 1991, was credited with significantly improving
diarrheal case management (National Control Of Diarrheal
Diseases Project 1988; El-Rafie et al. 1990; Cobb et al.
1996). However, over the last two decades, momentum has
slowed (Forsberg et al. 2007). As of the date of this report,
rotavirus vaccines have been introduced through National
Immunization Programs in only nine countries in the
region: Djibouti, Jordan, Libya, Morocco, Qatar, Saudi
Arabia, Sudan, United Arab Emirates, and Yemen
(PATH 2017).
In this report, we are updating our previous burden
estimates (Khalil et al. 2016), pathogen distribution, and
risk factors for diarrhea in children and adults in the EMR
for 1990–2015.
Methods
The Global Burden of Disease Study (GBD 2015) is a
systematic, comprehensive effort to quantify health loss
from more than 300 diseases and injuries, including diar-
rheal diseases and associated risk factors. The GBD esti-
mation strategy, including for diarrheal diseases, has been
described in detail elsewhere (Foreman et al. 2012; Flax-
man et al. 2015). The burden of diarrheal diseases is
measured in deaths, incidence, and disability-adjusted life-
years (DALYs), which are the sum of years of life lost
(YLLs) and years lived with disability (YLDs). The etio-
logical burden was also estimated for 13 pathogens asso-
ciated with diarrhea.
All estimates are produced by year and by age, for both
sexes, and for all countries. In accordance with the
guidelines for accurate and transparent health estimates
reporting (GATHER), code for each step of the estimation
process is available online on GitHub (http://www.ghdx.
healthdata.org/gbd-2015-code) (Institute for Health Met-
rics and Evaluation). The methods of each of these steps
are summarized below.
Study region
The EMR countries were grouped according to per capita
gross national income (GNI) into low-income countries
(LICs) [Islamic Republic of Afghanistan (Afghanistan),
Djibouti, Somalia, Republic of Yemen (Yemen)]; middle-
income countries (MICs) [Arab Republic of Egypt (Egypt),
Islamic republic of Iran (Iran), Iraq, Jordan, Lebanon,
Libya, Morocco, Pakistan, Palestine, Sudan, Syrian Arab
Republic (Syria), Tunisia]; and high-income countries
(HICs) [Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and
the United Arab Emirates (UAE)]. We defined LICs as
those having a per capita GNI of $1045 or less, MICs as
those with a per capita GNI between $1046 and $12,735,
and HICs as countries with per capita GNI of $12,736 or
greater (The World Bank 2016).
Mortality
Cause-specific mortality estimates for diarrheal diseases
were modeled using a Bayesian ensemble modeling pro-
cess (GBD 2015 Mortality and Causes of Death Collabo-
rators 2016). Diarrhea mortality data included vital
registration and verbal autopsy sources. The modeling
process estimated the mortality rate due to diarrhea for both
sexes from 1990 to 2015 for all age groups in every country
and subnational regions in select countries. We considered
the following covariates: education, lag-dependent income,
underweight, latitude, population density, improved water
and sanitation sources, diarrhea risk factors summary,
Socio-demographic Index (SDI), and rotavirus vaccine
coverage. The ensemble model approach allows for a suite
of models, weighted by out-of-sample predictive validity,
to inform the final estimates.
Morbidity
Diarrheal cases were defined as three or more loose stools
in a 24-h period. As with mortality, morbidity was modeled
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at every year, sex, age, and geographic location in GBD
2015. The morbidity model used DisMod-MR 2.1, a
Bayesian meta-analytic, age-integrating, mixed-effects
model which is available online on EpiViz (http://www.
vizhub/healthdata.org/epi) (Kassebaum et al. 2016). Diar-
rhea prevalence and incidence data from a systematic lit-
erature review, population-representative surveys, and
hospital and health care utilization data informed the non-
fatal model.
Etiologies
Diarrhea cases and deaths were attributed to pathogens
using a counterfactual approach that accounts for exposure
to pathogens and for the association between each patho-
gen and diarrhea. A systematic literature review on the
proportion of diarrhea cases that test positive for a set of
pathogens was updated for GBD 2015. These data were
used in the DisMod-MR framework to estimate the age,
sex, year, and geographic distribution of pathogens in
diarrheal episodes. The population attributable fraction
(PAF) was used to identify the fraction of diarrhea cases
and deaths due to each pathogen. The PAF was calculated
as: (GBD 2015 Mortality and Causes of Death Collabora-
tors 2016).
PAF ¼ Proportion  1  1
OR
 
;
where Proportion is the proportion of cases positive for a
pathogen and the odds ratio (OR) is the odds of diarrhea
given pathogen detection. The odds ratios were from a
systematic reanalysis of the Global Enteric Multicenter
Study (GEMS) (Kotloff et al. 2013), a multi-site case–
control study of moderate-to-severe diarrhea in children
under 5 that systematically tested nearly half of the original
GEMS samples using a molecular quantitative polymerase
chain reaction (qPCR) diagnostic (Liu et al. 2016). A
mixed-effects conditional logistic regression model esti-
mated the odds ratios for diarrhea including random effects
on site to account for geographic variation.
Since the odds of diarrhea given pathogen presence were
calculated using the qPCR diagnostic, we adjusted our
proportion estimates to be comparable to qPCR-based
estimates. The sensitivity and specificity of the non-
molecular diagnostic techniques from GEMS were evalu-
ated compared to the qPCR diagnostic, and these values
were used to make this adjustment with this formula
(Wickham 2009):
ProportionTrue ¼
ðProportionObserved  Specificity  1Þ
ðSensitivity þ Specificity  1Þ :
Vibrio cholerae and Clostridium difficile were estimated
separately from the other pathogens in GBD. Cholera cases
were estimated using proportion data from published
studies to calculate an expected number of annual cases for
each country and year, and those estimates were compared
to the World Health Organization case notification data
(WHO 2016) to estimate underreporting of cholera. Cho-
lera deaths were estimated using case fatality data in Dis-
Mod-MR. Since C. difficile is frequently associated with
hospital and health care utilization, hospital incidence data
were modeled in DisMod-MR using hospital and health
care utilization data with ICD codes for C. difficile.
All etiologies were estimated independently and for
each year, geography, age, and sex.
Risk factors
We also assessed diarrheal DALYs, YLLs, and YLDs
attributable to childhood stunting, suboptimal breastfeed-
ing, vitamin A deficiency, zinc deficiency, and water,
sanitation, and hygiene (WASH). Risk factor attribution
follows a general counterfactual approach where the
exposure and relative risk of diarrhea were used to estimate
the burden of the aforementioned risk factors (GBD 2015
Risk Factors Collaborators 2016).
Socio-demographic Index
We evaluate associations between diarrhea and socio-de-
mographic status using the Socio-demographic Index
(SDI). The SDI is a composite measure developed for GBD
2015 that accounts for fertility rate, lag-dependent income
per capita, and education (GBD 2015 Mortality and Causes
of Death Collaborators 2016). To capture the average
relationships for each age–sex group, we applied a simple
least squares spline regression of the diarrhea mortality rate
on SDI. The predicted diarrhea mortality rates from this
regression were used as expected mortality rates based on
SDI. The SDI is scaled from 0 to 1 where 0 represents the
lowest possible observed SDI and 1 is the highest. SDI in
2015 in the EMR ranged from 0.27 in Somalia to 0.83 in
Kuwait.
Results
There were 103,692 diarrhea deaths in the EMR in 2015
(95% uncertainty interval (UI): 87,018–124,692), and the
mortality rate was 16.0 deaths per 100,000 persons (95%
UI: 13.4–19.2). The majority of these deaths occurred in
children under 5 years old (63.3%) (65,670 deaths, 95%
UI: 53,640–79,486). Although the greatest number of
diarrhea deaths occurred in children under 5, diarrhea
mortality was also high in the 70? year age group. In fact,
of the 22 countries in the EMR, the mortality rate was
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higher in the 70? age group than the under-5 age group in
17 countries. Diarrhea mortality in the elderly was highest
in Somalia (1695 per 100,000, 95% UI: 709–2896), fol-
lowed by Djibouti and Pakistan (Table 1). Diarrhea mor-
tality decreased over time in the EMR (Table 2; Fig. 1).
Between 1990 and 2015, the number of diarrhea deaths
decreased by 54% among all ages (95% UI: 43–62%) and
65% among children under 5 (95% UI: 55–73%). The
fastest rate of decrease among children under 5 occurred in
Iran (97%, 95% UI: 93–99%) and Syria (97%, 95% UI:
94–99%) and the slowest occurred in Somalia (11%, 95%
UI: -40 to 45%) and Qatar (33%, 95% UI: -65 to 72%).
Diarrhea mortality among children under 5 varied by
time and country. The under-5 diarrhea mortality rate was
highest in Somalia, followed by Pakistan, Sudan, and
Afghanistan (Figs. 2, 3). Due to its high population, the
greatest number of under-5 deaths occurred in Pakistan
(55,500 deaths, 95% UI: 43,258–70,027). Diarrhea mor-
tality was associated with trends in the Socio-demographic
Index in most geographies (Figs. 2b, 3), but the mortality
rate was much lower in Palestine and Iraq than would be
expected based on SDI alone. The ratio of the observed
mortality rate to the expected mortality rate based on SDI
alone was lowest in Syria and Palestine, where mortality
was 3% of the expected value, and highest in Bahrain,
where the mortality was 65% higher than expected based
on SDI alone. Syria and Palestine have moderate SDI and
very low diarrhea mortality rates.
Diarrhea was also responsible for a large number of
illness episodes. In 2015, diarrhea incidence was 2.1 (95%
UI: 1.9–2.4) per child-year, totaling more than 171 million
episodes across the EMR. The incidence was much lower
in adults, including those 70? years old (0.7 per person-
year, 95% UI: 0.69–0.75). The case fatality, expressed as
the number of deaths over the number of cases, was 0.1%
in those 70? years old, significantly greater than in chil-
dren under 5 years (0.038%). Case fatality increased non-
linearly with incidence (e-Figure 1). Despite the large
observed reductions in diarrhea mortality between 1990
and 2015, diarrhea incidence decreased much more mar-
ginally (20.7%).
Among diarrheal etiologies, rotavirus was the leading
cause of death in 2015 among children under 5 (13,180
deaths, 95% UI: 9807–17,738), followed by Shigella
(10,964 deaths) and enterotoxigenic E. coli (ETEC) (6885
deaths) (Table 3 and e-Figure 1). Among all ages, Shigella
was the leading cause of diarrheal deaths (19,450 deaths,
95% UI: 10,026–33,996), followed by Aeromonas and
rotavirus. Overall, 99% of diarrheal deaths in 2015 were
attributed to at least one etiology (e-Figure 2).
Unsafe water, sanitation, and hygiene were responsible
for over 95% of diarrhea DALYs in the EMR in 2015
(95.1%, 95% UI: 89.2–98.1%), which is comparable with
the global total in 2015. The proportion of diarrhea DALYs
due to unsafe WASH was lowest in Jordan (87.0%) and
highest in Sudan (97.0%) (e-Figure 3). Childhood
Table 1 The number of diarrhea deaths and mortality rate (per 100,000) in 2015 in the Eastern Mediterranean Region for each age group and
sex (Global Burden of Disease 2015 study, Eastern Mediterranean Region, 2015)
Age Sex Deaths Rate
All ages Both 103,691.7 (87,018.3–124,692.2) 15.99 (13.42–19.23)
All ages Female 50,679.8 (40,407.1–63,194.3) 16.14 (12.87–20.12)
All ages Male 53,011.9 (42,617.5–65,304.5) 15.86 (12.75–19.53)
Under 5 Both 65,670.3 (53,639.7–79,485.9) 81.82 (66.83–99.04)
Under 5 Female 34,729.4 (26,435.3–45,011.1) 89.09 (67.81–115.46)
Under 5 Male 30,940.9 (23,892.9–39,342.5) 74.96 (57.89–95.32)
5–14 years Both 4986.1 (3724.4–6501.8) 3.67 (2.74–4.78)
5–14 years Female 2540.1 (1839.4–3414.2) 3.84 (2.78–5.16)
5–14 years Male 2446 (1623.7–3486.2) 3.5 (2.32–4.99)
15–49 years Both 11,546.4 (7917.3–18,792.8) 3.36 (2.3–5.47)
15–49 years Female 4827.5 (3205.6–8471.4) 2.93 (1.94–5.13)
15–49 years Male 6718.9 (4339.3–10,599.2) 3.76 (2.43–5.94)
50–69 years Both 9457.6 (6095.2–15,147.7) 13.21 (8.51–21.16)
50–69 years Female 3836.5 (2060–6875.3) 10.93 (5.87–19.58)
50–69 years Male 5621.1 (3578.4–8787.7) 15.41 (9.81–24.08)
70? years Both 12,031.2 (9097.8–15,593.3) 70.83 (53.56–91.8)
70? years Female 4746.3 (3404.3–6304.8) 53.74 (38.55–71.39)
70? years Male 7285 (5054.7–10,119.4) 89.34 (61.99–124.1)
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undernutrition was the second-leading risk factor for diar-
rheal DALYs, responsible for 74.0% (95% UI:
67.4–79.1%), which is significantly higher than the global
total (59.8%, 95% UI: 56.2–63.0%). Suboptimal breast-
feeding was responsible for 39.5% of diarrhea DALYs
among children under 5 (95% UI: 27.1–52.3%). Vitamin A
and zinc deficiency were responsible for less than 10% of
diarrhea DALYs among children under 5 (8 and 5%,
respectively) and were lower than the global average for
these risk factors (12.9 and 6.5%, respectively). Childhood
undernutrition PAF ranged from 41.1% in the United Arab
Emirates to 86.2% in Sudan. Diarrhea standardized expo-
sure variables (SEV), a measure of the prevalence-weigh-
ted risk of diarrhea, was highest in Sudan, Afghanistan, and
Yemen and lowest in the UAE, Jordan, and Kuwait.
Discussion
Our study is the most comprehensive assessment of diar-
rheal disease burden and the contributions of specific
pathogens and risk factors in the EMR to date. In 2015, the
estimated diarrhea-associated deaths and DALYs showed a
slight decline from the GBD 2013 estimates of 125,000 and
nearly 10 million, respectively. We also continue to find
significant variation within the region, with LICs and MICs
experiencing social unrest bearing the vast majority of
diarrheal burden. Our data clearly illustrate the gross health
inequity in the region: the HICs experienced a nominal
diarrhea burden compared to the substantial burden in all
LICs and some MICs.
There were no major methodological changes in diar-
rhea mortality modeling between GBD 2013 and GBD
2015 but there were updates to the cause of death and non-
fatal data. A major difference between GBD 2013 and 2015
was the introduction of the molecular diagnostic case
definition for diarrheal etiologies (Liu et al. 2014; GBD
2015 Mortality and Causes of Death Collaborators 2016;
GBD 2015 Risk Factors Collaborators 2016; Kassebaum
et al. 2016). In the current round of GBD, we used a sys-
tematic reanalysis of the Global Enteric Multicenter Study
(GEMS) that retested roughly half of the original 22,000
moderate-to-severe stool samples with quantitative poly-
merase chain reaction (qPCR) (Liu et al. 2016). In transi-
tioning to a molecular diagnostic case definition, we
attribute a much larger proportion of diarrhea cases and
deaths to etiologies compared to previous rounds of GBD
that used non-molecular diagnostics.
The Socio-demographic Index was designed to be a
measure of the socio-demographic status of a country and
is well correlated with the Human Development Index
(GBD 2015 Mortality and Causes of Death Collaborators
2016). Still, dramatic changes in development such asT
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those that have occurred since the start of political unrest in
some of the EMR countries, such as the Syrian civil war,
may be missed or at least result in a lag in the components
that make up the SDI including income, fertility, and
education. We have previously shown that the SDI is a
good marker of disease burden, but it may not entirely
capture major sociopolitical upheavals (GBD 2015 Mor-
tality and Causes of Death Collaborators 2016).
The introduction of vaccines against diarrheal pathogens
may exacerbate inequalities in diarrhea burden. For
example, although rotavirus infection was the largest
contributor to the diarrheal burden of disease, in some
countries in the region, rotavirus vaccine is only available
in the private market. This means that wealthier families,
who have less need for the vaccine, will gain the primary
benefit from its availability. This is troubling because
economic analyses of rotavirus vaccine introduction among
a number of EMR countries have uniformly suggested that
vaccine introduction would be cost-beneficial from a
societal perspective (Ortega et al. 2009; Connolly et al.
2012; Javanbakht et al. 2015). One study in Somalia (the
only LIC country) suggested that introduction of rotavirus
as a special immunization program during a complex
humanitarian emergency would meet WHO cost-effec-
tiveness benchmarks (Gargano et al. 2015).
One unique contribution of this analysis is the inclusion
of all age groups. Due to the high disease burden in young
children, nearly all diarrhea interventions and most diar-
rhea burden studies are limited to those under 5 years of
age (Boschi-Pinto et al. 2008; Fischer Walker et al. 2012;
Walker et al. 2013). However, the burden among those
over age 70 is substantial, with diarrheal disease-associated
deaths totaling nearly one sixth of the number among those
under 5. The elderly may face increased diarrhea risk due
to immunosenescence and comorbidities, which may also
necessitate special consideration in their treatment (Trinh
Fig. 1 Diarrhea mortality rate
per 100,000 population, by age,
1990–2015. The mortality rate
in the Eastern Mediterranean
Region is shown for six age
groups over time from 1990 to
2015. Points represent mean
estimates and error bars
represent 95% uncertainty
intervals (Global Burden of
Disease 2015 study, Eastern
Mediterranean Region,
1990–2015)
cFig. 2 Diarrhea mortality among children under 5 in the Eastern
Mediterranean Region, 2015. a The diarrhea mortality rate per
100,000 among children under 5 in 2015. b Ratio of the observed
under 5 diarrhea mortality rate in 2015 to the expected mortality rate
based on the Socio-demographic Index only. Values below 1 indicate
that the diarrhea mortality rate is lower than would be expected based
on the global relationship between mortality and SDI, and values
above 1 indicate higher mortality rates than would be expected
(Global Burden of Disease 2015 study, Eastern Mediterranean
Countries, 2015)
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Fig. 3 The diarrhea mortality rate per 100,000 for the Eastern
Mediterranean Region by country among children under 5 in 1990,
2000, and 2015. Countries are ordered from top to bottom from lowest
Socio-demographic Index (Somalia) to highest SDI (Qatar) based on
SDI values in 2015. Error bars illustrate the 95% uncertainty interval
for the estimates (Global Burden of Disease 2015 study, Eastern
Mediterranean Countries, 2015)
Table 3 The number of diarrhea deaths and the population attributable fraction (PAF) for 13 diarrheal etiologies among under-5 and all ages in
the Eastern Mediterranean Region, 2015 (Global Burden of Disease 2015 study, Eastern Mediterranean Region, 2015)
Etiology Under 5 All ages
Deaths PAF Deaths PAF
Adenovirus 4392.37 (1553.83 to 9530.86) 6.69 (2.47 to 13.85) 5285.33 (1885.13 to 11,110.37) 5.1 (1.87 to 10.34)
Aeromonas 3850.51 (0 to 29,059.34) 5.83 (-35.98 to
42.15)
15,315.61 (0 to -44,627.46) 14.72 (-12.52 to
41.55)
Amoebiasis 1446.31 (0 to 12,799.8) 2.19 (-10.65 to 20.4) 3075.66 (0 to 17,604.66) 2.97 (-3.01 to 17.06)
Campylobacter enteritis 5478.32 (1421.6 to 11,408.45) 8.3 (2.35 to 16.53) 5878.95 (1504.27 to 12,465.87) 5.66 (1.51 to 11.74)
Cholera 5142.08 (2784.31 to 9223.41) 7.86 (4.27 to 14.08) 9682.46 (5614.73 to 16,600.13) 9.38 (5.37 to 16.13)
Clostridium difficile 8.24 (4.89 to 13.04) 0.01 (0.01 to 0.02) 12.59 (8.99 to 17.62) 0.01 (0.01 to 0.02)
Cryptosporidiosis 4569.06 (801.68 to 11,545.02) 6.92 (1.26 to 16.99) 4796.2 (699.01 to 12,482.23) 4.62 (0.71 to 11.52)
Enteropathogenic E. coli
infection
1639.06 (132.28 to 4608.33) 2.49 (0.21 to 6.85) 1708.03 (141.29 to 4833.27) 1.64 (0.14 to 4.68)
Enterotoxigenic E. coli infection 6885.39 (2931.74 to 12,386.47) 10.47 (4.76 to 18.53) 11,102.89 (5152.14 to
20,035.61)
10.7 (4.92 to 18.28)
Norovirus 2402.25 (769.72 to 5439.75) 3.64 (1.26 to 8.03) 3935.54 (1027.17 to 8670.77) 3.78 (1.06 to 8.32)
Other salmonella infections 5559.16 (1663.31 to 12,323.64) 8.46 (2.57 to 18.31) 8752.77 (3002.34 to 18,462.75) 8.43 (3.01 to 17.61)
Rotaviral enteritis 13,180.3 (9807.01 to 17,738.4) 20.08 (16.37 to 25.56) 14,454.5 (10,983.35 to
18,974.79)
13.96 (11.13 to 17.68)
Shigellosis 10,963.91 (5480.23 to
19,387.69)
16.65 (9.02 to 28.57) 19,450.5 (10,025.55 to
33,996.23)
18.71 (10.32 to 30.61)
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and Prabhakar 2007). The increasing cholera burden in five
EMR countries (Jordan, Palestine, Syria, Bahrain, and
Oman) is a cause for concern, as neighboring countries
remain at high risk of transmission due to the presence and
movement of refugee populations among them.
We found no systematic difference in under-5 diarrhea
deaths or DALYs when comparing females to males. A
hypothesis that there may exists evidence of differential
diarrhea mortality burden by sex is supported by a previous
analysis of global demographic and health survey (DHS)
data. This analysis suggested that reported that girls
1–4 years old, particularly in the Middle Eastern crescent,
are at a mortality disadvantage compared to boys (Hill and
Upchurch 1995). This could be explained by differences in
health care access and nutritional status. Furthermore, an
Egyptian study found some evidence that, even when
parents sought care for their daughters with diarrhea,
regional health care providers provided biased treatment in
favor of boys (Yount 2003). In contrast, other studies, such
as a 2009 verbal autopsy study in Iraq, found no difference
in under-5 mortality by sex (Awqati et al. 2009).
Public health consequences of emergencies
in the region
The EMR is facing numerous health challenges as a result
of previous wars, and recent revolutions and the wars that
followed (Mokdad et al. 2016; Charara et al. 2017) resulted
in a huge refugee problem with millions of refugees and
massive consequences for the health and well-being of
millions of displaced people. The EMR now carries the
largest burden of displaced populations globally.
Out of a total of 50 million refugees and internally
displaced persons (IDPs) worldwide, more than 29 million
(9 million refugees and 20 million IDPs) came from the
region (WHO EMRO 2015). Syria is currently the world’s
largest source of refugees and IDPs, with more than 40% of
the population now displaced both inside the country and in
neighboring states. Afghanistan and Somalia face two of
the longest-spanning refugee situations, with Afghanis
constituting the second-largest refugee group in the world,
and Somalia facing one of the world’s most complex
refugee situations (WHO EMRO 2015). Over the past few
years, the region saw massive internal displacement in Iraq,
with more than 3 million people fleeing their homes since
June 2014, and in Yemen, where more than 2.3 million
people have been internally displaced since March 2015
(ACAPS 2015).
The impact of these emergencies on public health is
profound and enduring, affecting both the displaced pop-
ulations and host communities. The risk of DD is increased
in these settings due to limited access to safe water, rota-
virus vaccines, and oral rehydration salts, along with other
factors like infectious diseases, acute malnutrition, and
inappropriate infant and young child feeding. The lack of
safe drinking water as well as adequate sanitation and
hygiene is especially concerning as a major risk factor for
DD. Provision of a safe water supply, sanitation, and
hygiene is a crucial priority, even in these emergency
situations.
Study limitations
Our estimates of diarrhea mortality, morbidity, and etiol-
ogy attribution are limited by data availability, and
although our modeling process seeks to make use of all
available data, the number of relevant publications in the
region is limited and unbalanced between countries. The
hierarchical modeling approach allows us to ‘‘borrow’’
strength across time and geography to generate the best
possible estimates. Second, since we only account for the
acute phase of diarrhea in our YLD estimates, the resulting
DALYs severely underestimate diarrhea-associated mor-
bidity. In future GBD updates, we expect to include long-
term sequelae such as stunting and cognitive impairment,
(Moore et al. 2010; MacIntyre et al. 2014; Colombara et al.
2016) which will better estimate the true burden of disease.
Despite these limitations, this analysis also has several
strengths. GBD methodology ensures internal consistency
so that morbidity and mortality cannot be simultaneously
ascribed to competing causes and allows for comparability
between countries and across regions.
Conclusion
Increased momentum of public health efforts is needed to
reduce the burden of diarrhea in the EMR, especially in
lower-income countries and countries experiencing politi-
cal and social unrest.
Health inequities revealed in our study show that a
coordinated approach that involves prevention and treat-
ment is needed to address the multiple causes of diarrheal
diseases. Regional health systems need to be strengthened
to achieve the widespread availability and use of oral
rehydration salts, improved nutrition, better sanitation and
hygiene, and increased coverage of rotavirus immuniza-
tion. Improved rates of breastfeeding should be strongly
emphasized as one of the effective tools to prevent DD in
countries’ public health programs.
Due to the high relevance of rotavirus infections in the
EMR (Malek et al. 2010), there is also an urgent need to
accelerate the rollout of rotavirus vaccine in the region
through government immunization programs that would
ensure access for the children who are most in need. In
addition, regional governments should begin deliberation
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to integrate Shigella, ETEC, and other diarrheal vaccines
that are currently in preclinical and clinical trials into their
Expanded Programs on Immunization (EPI) as soon as they
are approved and licensed.
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